MAGENTA CLINICAL TRIAL Trademark
Trademark Overview
On Tuesday, December 10, 2024, a trademark application was filed for MAGENTA CLINICAL TRIAL with the United States Patent and Trademark Office. The USPTO has given the MAGENTA CLINICAL TRIAL trademark a serial number of 98895084. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, November 11, 2025. This trademark is owned by IGC Pharma IP, LLC. The MAGENTA CLINICAL TRIAL trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Medical and scientific research, namely, conducting clinical trials for others; Scientific research for medical purposes in the field of CNS (central nervous system) diseases
General Information
| Serial Number | 98895084 |
| Word Mark | MAGENTA CLINICAL TRIAL |
| Filing Date | Tuesday, December 10, 2024 |
| Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
| Status Date | Tuesday, November 11, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, September 16, 2025 |
Trademark Statements
| Goods and Services | Medical and scientific research, namely, conducting clinical trials for others; Scientific research for medical purposes in the field of CNS (central nervous system) diseases |
| NOT AVAILABLE | "CLINICAL TRIAL" |
| Description of Mark | The mark consists of the literal elements "MAGENTA CLINICAL TRIAL" where "MAGENTA" appears in a stylized, purple font above "CLINICAL TRIAL" which appears in a stylized, dark purple font. All of the literal elements appear to the right of a purple circle containing two dark purple rectangles and one purple rectangle. The color white represents background and is not part of the mark. |
| Indication of Colors claimed | The color(s) purple and dark purple is/are claimed as a feature of the mark. |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, December 10, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | IGC Pharma IP, LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Potomac, MD 20854 |
| Party Name | IGC Pharma IP, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Potomac, MD 20854 |
Trademark Events
| Event Date | Event Description |
| Tuesday, December 10, 2024 | NEW APPLICATION ENTERED |
| Tuesday, May 20, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, May 20, 2025 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Thursday, May 29, 2025 | ASSIGNED TO EXAMINER |
| Wednesday, June 11, 2025 | NON-FINAL ACTION WRITTEN |
| Wednesday, June 11, 2025 | NON-FINAL ACTION E-MAILED |
| Wednesday, June 11, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, August 11, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, August 11, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, August 11, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, August 13, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, September 10, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, September 16, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, September 16, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, November 11, 2025 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
